The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (63.12) USD. With the latest stock price at 5.72 USD, the upside of Regenxbio Inc based on DCF is -1203.5%.
Based on the latest price of 5.72 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1203.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.9% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (291.72) - (37.45) | (63.12) |
| Upside | -5200.0% - -754.7% | -1203.5% |